The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.

Researchers have developed a therapy to treat Stargardt disease, the most common form of inherited macular degeneration, ...

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

Inc., a clinical-stage biotechnology company focused on developing innovative therapies for retinal diseases with significant unmet needs, announced today that it has entered into an option agreement ...

D Molecular Therapeutics reaches agreement with FDA for phase 3 trial design of DME candidate 4D-150, showing promising ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be ...

Eggs are packed with essential nutrients, vitamins, and minerals that benefit immunity, bones, and overall health. They ...

Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 ...

Including antioxidant-rich foods such as blueberries, spinach, red bell peppers, tomatoes, kale, purple grapes, carrots, ...

An event aimed at raising awareness of the most common cause of sight loss in the UK will return to Doncaster next month.

Discover how your diet can improve vision health with essential nutrients, carotenoids, and food pairings for long-term eye ...